Evidence map›Paper›PMID 23416685›Full record

ArticleTransplantation2013

Upregulation of IL-1β, IL-6, and CCL-2 by a novel mouse model of pancreatic ischemia-reperfusion injury.

Keri E Lunsford, Brandon J Baird, Gregory D Sempowski, Diana M Cardona, Zhiguo Li, Kent J Weinhold, Debra L Sudan, Todd V Brennan

Abstract read
In one paragraph

Article in Transplantation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Sterile Pancreas Inflammation during Preservation and after Transplantation.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Normothermic ex situ pancreas perfusion for the preservation of porcine pancreas grafts.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Keri E LunsfordDepartment of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Brandon J Baird
Gregory D Sempowski
Diana M Cardona
Zhiguo Li
Kent J Weinhold
Debra L Sudan
Todd V Brennan
Duke Medical Center · USDuke University Hospital · USDuke University · US

Funding

Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
Role of Endogenous Toll-Like Receptor Ligands in Allospecific T Cell ActivationK08AI101263 · NIAID · DUKE UNIVERSITY · PI BRENNAN, TODD VICTOR · 2012 to 2016
$644k
NIAID NIH HHS K08 AI101263NIAID NIH HHS UC6 AI058607
6 · The paper itself

Abstract

backgroundLittle is known about the immunologic events surrounding pancreatic ischemia-reperfusion injury (IRI) because of a lack of established experimental models. The purpose of this study was to develop a mouse model for pancreatic IRI to serve as a basis for the immunologic characterization of pancreatic organ damage at transplantation.

methodsReversible ischemia was surgically induced by vascular isolation of the distal pancreas for 0, 10, 20, or 30 min. Mice receiving laparotomy without clamping served as sham-operated controls. After reperfusion, mice were serially assayed for biochemical and histologic evidence of inflammation, proinflammatory cytokine and chemokine production, and inflammatory gene upregulation.

resultsAfter induction of pancreatic IRI, serum amylase and lactate dehydrogenase peaked at 6 hr and returned to baseline by 120 hr after injury in all groups. Mice undergoing 30 min of IRI demonstrated the greatest biochemical evidence of inflammation. Histologic scoring similarly demonstrated marked inflammation in mice subjected to 30-min IRI compared with controls. Serum cytokine/chemokine analysis demonstrated significant upregulation of granulocyte colony-stimulating factor, interferon γ, tumor necrosis factor α, interleukin (IL)-2, IL-1β, IL-6, chemokine (C-C motif) ligand-2, chemokine (C-C motif) ligand-5, chemokine (C-X-C motif) ligand-1, and macrophage inflammatory protein 2. A similar upregulation of ccl2, il1b, il6, fos, hspa1a, hspd1, and cd14 gene expression was detected by real-time polymerase chain reaction analysis of pancreatic tissue.

conclusionsThis novel model of distal pancreatic IRI in the mouse demonstrates time-limited pancreatic inflammation and injury by histologic and biochemical indices. Inflammation may be, in part, a result of the immunologic effects of IL-1β, IL-6, and CCL-2. This model provides a method by which immunologic mechanisms of pancreatic IRI can be elucidated.

Indexed as

AnimalsChemokine CCL2Disease Models, AnimalInflammation MediatorsInterleukin-1betaInterleukin-6MiceMice, Inbred C57BLPancreasPancreas TransplantationReperfusion InjuryRNAUp-RegulationCcl2 protein, mouseChemokine CCL2Inflammation MediatorsInterleukin-1betaInterleukin-6RNA

Identifiers

PMID23416685
PMCPMC3629003
OpenAlexW2053040743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.